You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Newly diagnosed epilepsy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prevalence of Cognitive Disorders in Newly Diagnosed Epilepsy

Recruiting
  • Epilepsy
  • Cognition
  • Neuropsychological assessement and questionnaires
  • Nancy, France
    Department of neurology - Hospital of Nancy
Jan 11, 2022

Epilepsy Trial in Shanghai (psychology therapy)

Active, not recruiting
  • Epilepsy
  • psychology therapy
  • Shanghai, Shanghai, China
    Department of Neurology, Zhongshan Hospital, Fudan University, S
Dec 19, 2021

Cognitive Impairment, Epilepsy Trial in Assiut (Digital electroencephalography (EEG) for an hour (16 channels))

Not yet recruiting
  • Cognitive Impairment
  • Epilepsy
  • Digital electroencephalography (EEG) for an hour (16 channels)
  • Assiut, Egypt
    Shady Mohamed Safwat Mohamed Tawfik Hassan
Oct 2, 2021

Human Epilepsy Project 3

Recruiting
  • Idiopathic Generalized Epilepsy
    • San Francisco, California
    • +17 more
    May 11, 2022

    Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

    Not yet recruiting
    • Prostate Cancer
    • Newly-Diagnosed Prostate Cancer
    • (no location specified)
    Nov 3, 2023

    Newly Diagnosed Peripheral T-cell Lymphoma Trial in Wuhan (Duvelisib, Chidamide)

    Recruiting
    • Newly Diagnosed Peripheral T-cell Lymphoma
    • Duvelisib, Chidamide
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Jul 27, 2023

    nk/T-cell Lymphoma, Newly Diagnosed, Advanced Lymphoma Trial in Beijing (XPO1 inhibitor)

    Recruiting
    • nk/T-cell Lymphoma
    • +2 more
    • XPO1 inhibitor
    • Beijing, Haidian, China
      ChinaPLAGH
    Apr 18, 2023

    Type 1 Diabetes, Type 1 Diabetes (Juvenile Onset), Diabetes, Type 1 Trial in Indianapolis (HAMS-AB, Placebo)

    Not yet recruiting
    • Type 1 Diabetes
    • +2 more
    • Indianapolis, Indiana
      Indiana School of Medicine
    Sep 28, 2023

    Feasibility Trial in Glostrup (NISMA)

    Completed
    • Feasibility
    • NISMA
    • Glostrup, Region Hovedstaden, Denmark
      Luise Holberg Lindgren
    Sep 26, 2023

    Oncology, Psychological Distress Trial (mHealth-delivered music breathing therapy, Online educational modules)

    Not yet recruiting
    • Oncology
    • Psychological Distress
    • mHealth-delivered music breathing therapy
    • Online educational modules
    • (no location specified)
    Sep 19, 2023

    Multiple Sclerosis Trial in Istanbul (Structured exercise training)

    Not yet recruiting
    • Multiple Sclerosis
    • Structured exercise training
    • Istanbul, Turkey
      Feray Güngör
    Jul 16, 2023

    Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)

    Not yet recruiting
    • Classic Hodgkin Lymphoma
    • Concurrent penpulimab and AVD
    • Sequential penpulimab and AVD
    • (no location specified)
    Jul 10, 2023

    Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

    Not yet recruiting
    • Acute Myeloid Leukemia in Children
    • Standard Intervention
    • Investigational Intervention
    • (no location specified)
    Aug 8, 2023

    HIV, Hiv Trial (Community Antiretroviral Therapy)

    Not yet recruiting
    • HIV Infections
    • Hiv
    • Community Antiretroviral Therapy
    • (no location specified)
    Nov 6, 2023

    Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)

    Recruiting
    • Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
    • Olverembatinib plus venetoclax and dexamethasone
    • Xi'an, Shannxi, China
      Department of Hematology, Xijing Hospital, Fourth Military Medic
    Oct 9, 2023

    Multiple Sclerosis (MS) Trial in Birmingham (Physical activity behavioral intervention in persons newly diagnosed with MS)

    Recruiting
    • Multiple Sclerosis (MS)
    • Physical activity behavioral intervention in persons newly diagnosed with MS
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jan 24, 2023

    Glioblastoma Multiforme Trial (WP1066)

    Not yet recruiting
    • Glioblastoma Multiforme
    • (no location specified)
    May 18, 2023

    Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)

    Recruiting
    • Newly Diagnosed Peripheral T-cell Lymphoma
    • Nanjing, Jiangsu, China
      Hematological Department, People's Hospital of Jiangsu Province
    Jun 1, 2023

    Clinical Pathways for Newly Diagnosed Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma
    • Multiple Myeloma Without Mention of Remission
    • Multiple Myeloma Pathway
    • +2 more
    • (no location specified)
    Nov 27, 2023

    PCNSL Trial in Shanghai (Zanubrutinib, Rituximab, Methotrexate)

    Not yet recruiting
    • PCNSL
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Jun 8, 2023

    Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

    Not yet recruiting
    • Lymphoma, Mantle-Cell
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Nov 14, 2023

    Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)

    Not yet recruiting
    • Light Chain (AL) Amyloidosis
    • +2 more
    • (no location specified)
    Aug 16, 2023

    Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma
    • Frailty
      • (no location specified)
      Oct 30, 2023

      Non-hodgkin Lymphoma Trial (Methotrexate, Rituximab (where available), Ibrutinib)

      Not yet recruiting
      • Non-hodgkin Lymphoma
      • (no location specified)
      Aug 11, 2023

      Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)

      Not yet recruiting
      • Newly Diagnosed Glioblastoma
      • (no location specified)
      Feb 13, 2023